Descripción de negocio
HAEMATO AG was founded in 1993 and is a stock exchange quoted pharmaceutical company. The company is listed on the Frankfurt Stock Exchange in the Entry Standard (Open Market) and is based in Schönefeld / Germany. HAEMATO AG is active within the pharmaceutical industry and is specialized in the growing markets of patent protected and patent free medications. The core focus lies in the therapeutic areas oncology, HIV/AIDS and other chronic diseases.
Consejo de gestión & Consejo de supervisión
| CEO |
| Patrick Brenske |
| Consejo de gestión |
| Attila Strauss |
| Consejo de supervisión |
| Andrea Grosse, Prof. Dr. Dr. Sabine Meck, Uwe Zimdars |
Datos de la empresa
| Nombre: |
HAEMATO AG |
| Dirección: |
Lilienthalstraße 5c,D-12529 Schönefeld |
| Teléfono: |
+49-30-677-9867-600 |
| Fax: |
+49-30-677-9867-707 |
| E-mail: |
service@haemato.de
|
| Internet: |
www.haemato.de |
| Industria: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Subsector: |
Pharmaceuticals |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
24.20% |
| Fecha de OPI: |
05/12/2005 |
Relación con inversores
| Nombre: |
- |
| IR teléfono: |
- |
| IR-fax: |
- |
| IR e-mail: |
ir@haemato.de
|
